| Follow up period after HIFU | 7 - 159 months (median 46.5) | No. of patients |
| PSA nadir (PSA ng/ml) | 0.008 - 0.789 (median 0.088) | |
| 1 - 21 months (median 1.5) | ||
| <0.01 | 4 | |
| 0.01 - <0.2 | 10 | |
| 0.2 - <0.4 | 1 | |
| ≥0.4 | 1 | |
| Disease free survival rate | 1 year 50.0% | |
| 2 year 37.5 | ||
| 3 year 31.3 | ||
| 4 year 31.3 | ||
| 5 year 31.3 | ||
| PSA result of salvage HIFU | ||
| <0.2 | 4 | |
| <0.4 over 24 months | 5 | |
| <0.4 under12 months | 4 | |
| >0.4 under 12 months | 3 | |
| Adverse effects at 1 - 3 months after HIFU | ||
| Difficult voiding | G1 2, G2 3 | |
| Urinary incontinence | G1 2, G2 1 | |
| Recto-urethral fistula | 0 | |